MADISON,
Wis., May 2, 2022 /PRNewswire/ -- Exact Sciences
Corp. (NASDAQ: EXAS), a leader in advanced cancer diagnostics,
today announced that company management will participate in the
following conference and invited investors to participate by
webcast.
- BofA Securities Healthcare Conference, Las Vegas
Fireside Chat on Wednesday, May 11,
2022 at 5:00 p.m. ET
The webcast can be accessed in the investor relations section of
Exact Sciences' website at www.exactsciences.com.
About Exact Sciences
Corp.
A leading provider of cancer screening and diagnostic tests,
Exact Sciences relentlessly pursues smarter solutions providing the
clarity to take life-changing action, earlier. Building on the
success of Cologuard and Oncotype tests, Exact Sciences is
investing in its product pipeline to support patients before and
throughout their cancer diagnosis and treatment. Exact Sciences
unites visionary collaborators to help advance the fight against
cancer. For more information, please visit the company's website at
www.exactsciences.com, follow Exact Sciences on Twitter
@ExactSciences, or find Exact Sciences on Facebook.
Contact:
Megan
Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815
View original content to download
multimedia:https://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-may-investor-conference-301536912.html
SOURCE Exact Sciences Corporation